Lipocortin.
In this short article the author has attempted to review some of the areas of lipocortin research which are currently of interest. The area has become an extraordinary complex one with many conflicting claims in the literature, on the other hand there are enough interesting leads in the work that has already been done to encourage further research into this fascinating family of membrane-based regulatory molecules.
Flower
R J
RJ
Department of Biochemical Pharmacology, St. Bartholomew's Hospital Medical College, London, U.K.
D000818:Animals; D017302:Annexins; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D003001:Cloning, Molecular; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D011994:Recombinant Proteins / Q000494:pharmacology; D013256:Steroids / Q000494:pharmacology
D017302:Annexins; D002135:Calcium-Binding Proteins; D011994:Recombinant Proteins; D013256:Steroids; D010741:Phospholipases A